William P. Steward

23.3k citations

221 papers · 18.3k indexed · 6 hit papers · h-index 67

Molecular Medicine top 0.02%
- Curcumin's Biomedical Applications 25
Geriatrics and Gerontology top 0.05%
Biochemistry top 0.1%
- Phytochemicals and Antioxidant Activities 17
Oncology top 0.5%
- Cancer Treatment and Pharmacology 20
- Colorectal Cancer Treatments and Studies 16
Cancer Research top 0.5%
Molecular Biology
- Natural product bioactivities and synthesis 18
- Genomics, phytochemicals, and oxidative stress 17
Pulmonary and Respiratory Medicine
- Sarcoma Diagnosis and Treatment 15
Pharmacology
- Inflammatory mediators and NSAID effects 15

Co-authors: Andreas J. Gescher Ricky A. Sharma Karen Brown Timothy H. Marczylo Ketan Patel Victoria Brown Giuseppe Garcea Darren N. Cooke
Cited by: Molecular Medicine Geriatrics and Gerontology Biochemistry
Partner nations: United Kingdom United States Italy

In The Last Decade

William P. Steward

218 papers receiving 17.6k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
2009 Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
2007 Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent
2005 Curcumin: The story so far
2004 Phase I Clinical Trial of Oral Curcumin
2001 Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

Peers

Countries citing papers authored by William P. Steward

Since Specialization

Citations

This map shows the geographic impact of William P. Steward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William P. Steward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William P. Steward more than expected).

Fields of papers citing papers by William P. Steward

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William P. Steward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William P. Steward. The network helps show where William P. Steward may publish in the future.

Co-authorship network

The 25 scholars most cited alongside William P. Steward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William P. Steward Line = papers co-authored together William P. Steward links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity? Hong Cai,Edwina N. Scott,Robert G. Britton,Emma Parrott,Ted Ognibene,Michael Malfatti,Masood A. Khan,William P. Steward,Karen Brown	2020	13
2	Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial Lynne Howells,Chinenye Iwuji,Glen R.B. Irving,Shaun Barber,Harriet S. Walter,Zahirah Sidat,Nicola Griffin-Teall,Raj Singh,Nalini Foreman,Samita R. Patel,Bruno Morgan,William P. Steward,Andreas J. Gescher,Anne Thomas,Karen Brown	2019	181
3	Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial Alison Backen,Andre Lopes,Harpreet Wasan,Daniel H. Palmer,Marian Duggan,David Cunningham,Alan Anthoney,Pippa Corrie,Srinivasan Madhusudan,Anthony Maraveyas,Paul J. Ross,Justin S. Waters,William P. Steward,Charlotte Rees,Mairéad G. McNamara,Sandy Beare,John Bridgewater,Caroline Dive,Juan W. Valle	2018	22
4	Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials Axel Le Cesne,M. Ouali,Michael Leahy,Armando Santoro,Harald J. Hoekstra,Peter Hohenberger,Frits van Coevorden,Piotr Rutkowski,René van Hoesel,Jaap Verweij,Sylvie Bonvalot,William P. Steward,Alessandro Gronchi,Pancras C.W. Hogendoorn,Saskia Litière,Sandrine Marréaud,Jean‐Yves Blay,Winette T.A. van der Graaf	2014	118
5	Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancer Friederike Teichert,Richard D. Verschoyle,Peter Greaves,Donald J. L. Jones,Ian D. Wilson,Peter B. Farmer,William P. Steward,Andreas J. Gescher,Hector C. Keun	2010	3
6	Pilot Study of Oral Anthocyanins for Colorectal Cancer Chemoprevention Sarah Thomasset,David P. Berry,Hong Cai,Kevin West,Tim Marczylo,Debbie A. Marsden,Karen Brown,Ashley R. Dennison,Giuseppe Garcea,Andrew M. Miller,David Hemingway,William P. Steward,Andreas J. Gescher	2009	90
7	Development of Dietary Phytochemical Chemopreventive Agents: Biomarkers and Choice of Dose for Early Clinical Trials Edwina N. Scott,Andreas J. Gescher,William P. Steward,Karen Brown	2009	58
8	Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: Relationship with silibinin levels Richard D. Verschoyle,Peter Greaves,Ketan Patel,Debbie A. Marsden,Karen Brown,William P. Steward,Andreas J. Gescher	2008	37
9	Modulation of response to cancer chemotherapeutic agents by diet constituents – Is the available evidence sufficiently robust for rational advice for patients? Maurizio D’Incalci,William P. Steward,Andreas J. Gescher	2007	10
10	Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis Richard D. Verschoyle,Peter Greaves,Hong Cai,Richard Edwards,William P. Steward,Andreas J. Gescher	2007	58
11	Curcumin: The story so farbreakdown → Ricky A. Sharma,Andreas J. Gescher,William P. Steward	2005	1400
12	The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease Kenneth J. O’Byrne,Angus Dalgleish,Michael J. Browning,William P. Steward,Adrian L. Harris	2000	7
13	Marimastat (BB2516): Current status of development William P. Steward	1999	113
14	The Role of Chemotherapy in the Treatment of Adult Soft Tissue Sarcomas Kenneth J. O’Byrne,William P. Steward	1999	29
15	Didemnin B in favourable histology non-Hodgkin's lymphoma Glenwood Goss,A. Muldal,Reinhard Lohmann,Margaret Taylor,(unknown),G. Armitage,William P. Steward	1995	9
16	Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer. Elisângela de Jesus Campos,John Radford,William P. Steward,Robert Milroy,M Dougal,R. Swindell,NG Testa,N. Thatcher	1995	51
17	Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. J Prendiville,John Radford,N. Thatcher,William P. Steward,Malcolm Ranson,P.A. Burt,R. Stout	1991	24
18	EORTC joint ventures in quality control: Treatment-related variables and data acquisition in chemotherapy trials K. Vantongelen,William P. Steward,G. Blackledge,Jaap Verweij,A. Van Oosterom	1991	33
19	Identification of an extended N-acetylated sequence adjacent to the protein-linkage region of fibroblast heparan sulphate Malcolm Lyon,William P. Steward,Ian Hampson,J T Gallagher	1987	39
20	Structure and function of heparan sulphate proteoglycans J. T. Gallagher,Malcolm Lyon,William P. Steward	1986	429

About William P. Steward

William P. Steward is a scholar working on Molecular Medicine, Oncology and Biochemistry, having authored 221 papers that have together received 18.3k indexed citations. Recurring topics across this work include Curcumin's Biomedical Applications (25 papers), Cancer Treatment and Pharmacology (20 papers), Natural product bioactivities and synthesis (18 papers), Genomics, phytochemicals, and oxidative stress (17 papers), Phytochemicals and Antioxidant Activities (17 papers), Colorectal Cancer Treatments and Studies (16 papers), Sarcoma Diagnosis and Treatment (15 papers) and Inflammatory mediators and NSAID effects (15 papers). The work is most often cited by research in Molecular Medicine (5.0k citations), Geriatrics and Gerontology (1.9k citations) and Biochemistry (1.7k citations). William P. Steward has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Andreas J. Gescher, Ricky A. Sharma, Karen Brown, Timothy H. Marczylo, Ketan Patel, Victoria Brown, Giuseppe Garcea, Darren N. Cooke, Richard D. Verschoyle and Ashley R. Dennison.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact